Clin2
NCT07464483Likely a fitRecruiting

Studying genetics in stem cell and CAR-T therapy patients

Bone Marrow Replaced Via Transplant

Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.

This trial analyzes genetic information from patients receiving a stem cell transplant or CAR-T therapy to better understand treatment outcomes. Participation may help researchers improve future therapies.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
260 people
Ages
Any age
Study type
Interventional

Who can take part

  • You are receiving a stem cell transplant from a donor (allogeneic) or CAR-T cell therapy for any condition
  • You or your legal guardian can sign a consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05807789Recruiting
Genetic testing during CAR-T treatment for adults

This study looks at a patient’s genetic (molecular) information while they receive CAR-T cell therapy. The goal is to better understand how different biological factors may affect CAR-T treatment.

Bologna, Italy
NCT04892433Recruiting
Tissue study for people getting CAR-T cell therapy

This study looks at tissue samples from adults who are receiving CAR-T cell therapy for blood-related conditions. It aims to learn more about how CAR-T works and what changes happen in the body, which may help improve future care.

Bologna, Italy
NCT06630104Recruiting
Studying blood cell changes after CAR-T therapy for blood cancers

This study looks at how CAR-T therapy affects blood cell counts (cytopenia) in people with multiple myeloma or certain lymphomas/leukemias. You will provide biological samples to help researchers understand these effects.

Scottsdale, Arizona
NCT01890486Recruiting
Collecting information from people having a stem cell transplant

This study aims to collect, store, and share data from patients who are receiving standard intensive treatment and a stem cell transplant from either their own cells or a donor. It may help improve how future patients are treated by building a reliable record of outcomes and care patterns.

Winston-Salem, North Carolina
NCT06856226Recruiting
Drug metabolism study for stem cell transplant patients

This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.

Bethesda, Maryland
NCT06787560Recruiting· Early Phase 1
CAR-T cells and stem cell transplant for blood diseases

This trial tests a new approach for people with non-cancerous blood and immune system diseases. It uses your own engineered immune cells (CAR-T cells) to prepare your body for a stem cell transplant from a relative.

Hangzhou, Zhejiang

Hear when a new Bone Marrow Replaced Via Transplant trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.